scispace - formally typeset
D

David Spiegel

Researcher at Stanford University

Publications -  838
Citations -  50967

David Spiegel is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 106, co-authored 733 publications receiving 46276 citations. Previous affiliations of David Spiegel include Tel Aviv University & University of Adelaide.

Papers
More filters
Journal ArticleDOI

Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression

TL;DR: In this paper, the authors provide updated information on psychotherapeutic interventions geared towards cancer patients suffering from depressive disorders, and its impact on disease progression, including depression associated with impaired immune response and poorer survival in patients with cancer.
Journal ArticleDOI

Exploring post-translational arginine modification using chemically synthesized methylglyoxal hydroimidazolones.

TL;DR: Efficient, multigram-scale syntheses of all MG-H-amino acid building blocks are developed, suitably protected for solid-phase peptide synthesis, in 2-3 steps starting from inexpensive, readily available starting materials, and expect the synthetic reagents reported herein to enable investigations into non-enzymatic protein regulation at an unprecedented level of detail.
Journal ArticleDOI

Glyoxalase Goes Green: The Expanding Roles of Glyoxalase in Plants.

TL;DR: The ubiquitous glyoxalase enzymatic pathway is involved in the detoxification of methylglyoxal (MG), a cytotoxic byproduct of glycolysis, and has been shown to be important for pollination responses.
Journal ArticleDOI

Family environment as a predictor of psychiatric rehospitalization.

TL;DR: Family environment was a better predictor of rehospitalization than baseline ratings of clinical status, indicating the importance of family support in the community adjustment of chronic psychiatric patients.
Journal ArticleDOI

Subjective sleep and overall survival in chemotherapy-naïve patients with metastatic colorectal cancer.

TL;DR: Subjective sleep problems are associated with poor clinical outcomes in metastatic colorectal cancer patients and affect chronotherapy effectiveness, and there is a need for a well-tuned circadian timing system in order to increase chronotherapy activity.